THE IMPACT OF LETERMOVIR PROPHYLAXIS IN MATCHED SIBLING DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION: SELECTING THE APPROPRIATE POPULATION FOR RATIONAL PROPHYLACTIC THERAPY (EHA 2025) - May 16, 2025 - Abstract #PF1221; Pres time: Jun 13, 2025; 06:30 PM - 07:30 PM; Location: Poster Hall; "In conclusions, for HSCT recipients from matched siblings, CMV prophylaxis strategies should be guided by risk stratification rather than solely relying on CMV serological status, which is valuable to optimize the prevention strategy. Further validation through larger clinical studies is needed."
Clinical • Acute Graft versus Host Disease • Bone Marrow Transplantation • Cytomegalovirus Infection • Epstein-Barr Virus Infections • Graft versus Host Disease • Immunology • Transplantation
|
|
Sisi Zhen; Zhangjie Chen; Yumeng Zhao; Donglin yang; Yi He; Aiming Pang; Erlie Jiang; Mingzhe Han; Sizhou Feng
|